BIRMINGHAM, Ala.--(BUSINESS WIRE)--Atherotech, Inc., a pioneer in cardiodiagnostic technology, today announced that it has appointed James Ehrlich, M.D. as Chief Medical Officer. In his new role, Ehrlich, a veteran in the development of advanced coronary risk assessment centers in major metropolitan cities, will continue to educate the healthcare community and the public about the critical role of Atherotech’s VAP ™ Cholesterol Test in preventive cardiology.
